Hepatitis Clinical Trials

Showing 521-540 of 1,819 trials

Cameroon HepB Birth Dose Feasibility Pilot

NCT04893616

This feasibility assessment is to provide quantitative findings of an intervention integrating immunizations into maternity and newborn care across 15 health facilities in Cameroon.

Hepatitis B

Clinton Health Access Initiative Inc.13 participantsStarted Jun 2021

Dibi, Adamaoua Region, Cameroon • Mbé, Adamawe, Cameroon • Biyem Assi, Center, Cameroon +10 more locations

COMPLETEDPhase 2

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

NCT01058512

The purpose of this research study is to find out the effect of the investigational drug NOV-205 on the level of hepatitis C virus in the blood and whether NOV-205 is well-tolerated at different doses when taken by subjects with hepatitis C.

Hepatitis C

Cellectar Biosciences, Inc.22 participantsStarted Mar 2010

Jacksonville, Florida, United States • Miami, Florida, United States • Orlando, Florida, United States +3 more locations

Cameroon HepB Birth Dose Feasibility Pilot

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

Related Searches

Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Study on Clinical Program Optimization of Inactive Hepatitis B Surface Antigen (HBsAg) Carriers (IHCs)

An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis

FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis

EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity

Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant

Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)

Evaluating the Chain of Addiction Care (CAC)

An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment

Hepatitis B Research Network Pediatric Cohort Study (HBRN)

Treatment and Prognosis of Patients With Chronic HBV Infection

Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B

Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor